Wayback Machine
Nov DEC Jan
Previous capture 21 Next capture
2014 2015 2016
1 captures
21 Dec 15 - 21 Dec 15
sparklines
Close Help
Skip to main content

Access brought to you by: LOCKSS

Login

MD Conference Express
Advanced Search

Main menu

  • HOME
  • BROWSE BY CONFERENCE
  • BROWSE BY DISCIPLINE
    • -- All Disciplines --
    • Anesthesiology
    • Cardiology & Cardiovascular Medicine
    • Dentistry
    • Dermatology
    • Endocrinology, Diabetes & Metabolism
    • Emergency Medicine & Critical Care
    • Hematology
    • Hepatology
    • Infectious Diseases
    • Nephrology
    • Neurology
    • Nutrition
    • Obstetrics & Gynecology
    • Oncology
    • Ophthalmology
    • Orthopaedics & Sports Medicine
    • Psychiatry & Psychology
    • Pulmonary & Respiratory Medicine
    • Radiology
    • Rheumatology
    • Veterinary Medicine
  • ABOUT
    • About Us
    • International Medical Advisory Board
    • Reprints
    • Librarian resources
    • Contact us
    • Help

Demyelinating Diseases

  • DECIDE: Significantly Improved Brain MRI Results with DAC HYP versus Interferon in RRMS
  • CARE-MS II Follow-up: Improvements with Alemtuzumab Maintained for 4 Years
  • ADVANCE Results: PEG-IFN-β-1a Decreases Disability in RRMS
  • CARE-MS I Follow-up: Alemtuzumab Efficacy, Safety for MS Treatment Maintained for More than 4 Years
  • ADVANCE Trial: PEG-IFN-β-1a Every 2 Weeks Significantly Improved Outcomes over 2 Years in RRMS
  • RPC1063 Safe and Effective in RRMS
  • BRAVO Analysis: Laquinimod Reduces Brain Atrophy in Patients with RRMS
  • New MS Drugs
  • Can the Damage in MS Be Repaired?
  • DMT Use during Pregnancy

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4

Other Products from SAGE / CQ Press

  • SAGE Journals
  • SAGE Knowledge
  • SAGE Research Methods
  • Help
Copyright © by SAGE Publications
Online ISSN: 1559-8977